Invention Grant
- Patent Title: N-pyridin-3-yl or N-pyrazin-2-yl carboxamides
- Patent Title (中): N-吡啶-3-基或N-吡嗪-2-基甲酰胺
-
Application No.: US13267920Application Date: 2011-10-07
-
Publication No.: US08410107B2Publication Date: 2013-04-02
- Inventor: Uwe Grether , Paul Hebeisen , Torsten Hoffmann , Stephan Roever
- Applicant: Uwe Grether , Paul Hebeisen , Torsten Hoffmann , Stephan Roever
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Patricia S. Rocha-Tramaloni; Gene J. Yao
- Priority: EP10187724 20101015
- Main IPC: A61K31/4965
- IPC: A61K31/4965 ; A61K31/44
Abstract:
The present invention relates to compounds of formula I, wherein A, R1 to R7 are defined in the description, and to pharmaceutically acceptable salts thereof. The present invention also relates to the manufacture of such compounds or their pharmaceutically acceptable salts, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as dyslipidemia, atherosclerosis and cardiovascular diseases.
Public/Granted literature
- US20120094993A1 N-PYRIDIN-3-YL OR N-PYRAZIN-2-YL CARBOXAMIDES Public/Granted day:2012-04-19
Information query
